Dr. Vanessa Zann's headshot

Dr. Vanessa Zann

Vice President, Scientific Consulting, Translational Pharmaceutics & Clinical Pharmacology - USA

About

Dr. Vanessa Zann, Vice President, Scientific Consulting, Translational Pharmaceutics & Clinical Pharmacology - USA, has over twenty-five years industry experience providing expert biopharmaceutic support to drug discovery, early drug development and clinical program design.

Vanessa holds a PhD in Pharmaceutical Science from Aston University, and completed postdoctoral research in buccal transport, before joining AstraZeneca as a permeability expert in the Pharmaceutical Development department, leading the global Caco-2 facility and selection of new chemical entities with appropriate biopharmaceutical properties.  

Since joining Quotient Sciences in 2012, Vanessa has provided study design and scientific leadership to over 100 clinical pharmacology and drug product optimization studies across a wide range of applications including first-in-human, drug-drug interaction and development and optimization of solubility enhanced and modified release formulations. She led the implementation of modelling and simulation services and application of in-vitro characterization strategies to Quotients development programs.  

How does Translational Pharmaceutics® disrupt drug development?
Learn how we conduct Translational Pharmaceutics® from our U.S. facilities and the difference that it makes in drug development: Q&A with Drs. Vanessa Zann and Helen Baker
Get in touch
Humanity can't afford to wait, so neither can we.